Cargando…

Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Detalles Bibliográficos
Autores principales: Li, Zhilin, Cai, Hao, Li, Zhiqian, Ren, Long, Ma, Xuelei, Zhu, Hongyan, Gong, Qiyong, Zhang, Hu, Gu, Zhongwei, Luo, Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520069/
https://www.ncbi.nlm.nih.gov/pubmed/36203964
http://dx.doi.org/10.1016/j.bioactmat.2022.09.016
_version_ 1784799541429534720
author Li, Zhilin
Cai, Hao
Li, Zhiqian
Ren, Long
Ma, Xuelei
Zhu, Hongyan
Gong, Qiyong
Zhang, Hu
Gu, Zhongwei
Luo, Kui
author_facet Li, Zhilin
Cai, Hao
Li, Zhiqian
Ren, Long
Ma, Xuelei
Zhu, Hongyan
Gong, Qiyong
Zhang, Hu
Gu, Zhongwei
Luo, Kui
author_sort Li, Zhilin
collection PubMed
description
format Online
Article
Text
id pubmed-9520069
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher KeAi Publishing
record_format MEDLINE/PubMed
spelling pubmed-95200692022-10-05 Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312] Li, Zhilin Cai, Hao Li, Zhiqian Ren, Long Ma, Xuelei Zhu, Hongyan Gong, Qiyong Zhang, Hu Gu, Zhongwei Luo, Kui Bioact Mater Corrigendum KeAi Publishing 2022-09-26 /pmc/articles/PMC9520069/ /pubmed/36203964 http://dx.doi.org/10.1016/j.bioactmat.2022.09.016 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Corrigendum
Li, Zhilin
Cai, Hao
Li, Zhiqian
Ren, Long
Ma, Xuelei
Zhu, Hongyan
Gong, Qiyong
Zhang, Hu
Gu, Zhongwei
Luo, Kui
Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]
title Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]
title_full Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]
title_fullStr Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]
title_full_unstemmed Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]
title_short Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]
title_sort corrigendum to “a tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-pd-l1 antibody” [bioact. mater. 21 299–312]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520069/
https://www.ncbi.nlm.nih.gov/pubmed/36203964
http://dx.doi.org/10.1016/j.bioactmat.2022.09.016
work_keys_str_mv AT lizhilin corrigendumtoatumorcellmembranecoatedselfamplifiednanosystemasananovaccinetoboostthetherapeuticeffectofantipdl1antibodybioactmater21299312
AT caihao corrigendumtoatumorcellmembranecoatedselfamplifiednanosystemasananovaccinetoboostthetherapeuticeffectofantipdl1antibodybioactmater21299312
AT lizhiqian corrigendumtoatumorcellmembranecoatedselfamplifiednanosystemasananovaccinetoboostthetherapeuticeffectofantipdl1antibodybioactmater21299312
AT renlong corrigendumtoatumorcellmembranecoatedselfamplifiednanosystemasananovaccinetoboostthetherapeuticeffectofantipdl1antibodybioactmater21299312
AT maxuelei corrigendumtoatumorcellmembranecoatedselfamplifiednanosystemasananovaccinetoboostthetherapeuticeffectofantipdl1antibodybioactmater21299312
AT zhuhongyan corrigendumtoatumorcellmembranecoatedselfamplifiednanosystemasananovaccinetoboostthetherapeuticeffectofantipdl1antibodybioactmater21299312
AT gongqiyong corrigendumtoatumorcellmembranecoatedselfamplifiednanosystemasananovaccinetoboostthetherapeuticeffectofantipdl1antibodybioactmater21299312
AT zhanghu corrigendumtoatumorcellmembranecoatedselfamplifiednanosystemasananovaccinetoboostthetherapeuticeffectofantipdl1antibodybioactmater21299312
AT guzhongwei corrigendumtoatumorcellmembranecoatedselfamplifiednanosystemasananovaccinetoboostthetherapeuticeffectofantipdl1antibodybioactmater21299312
AT luokui corrigendumtoatumorcellmembranecoatedselfamplifiednanosystemasananovaccinetoboostthetherapeuticeffectofantipdl1antibodybioactmater21299312